Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Week in Review: Suzhou's Adagene to Stage $125 Million IPO on NASDAQ

Sinovac to Expand Production of COVID-19 Vaccine to 2 Billion Doses

Adagene of Suzhou Files for $125 Million US IPO

Elpiscience Signs $117 Million Deal for TRIGR Bispecific

Immunotech of Beijing In-licenses Immunotherapy from T-Cure

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China